Ekso Bionics
EKSO
Operating Margin for Ekso Bionics (EKSO)
Operating Margin as of June 2024 (TTM): -102.64%
According to Ekso Bionics 's latest financial reports and stock price the company's current Operating Margin is -102.64%. At the end of 2021 the company had an Operating Margin of -86.82%.
Operating Margin history for Ekso Bionics from 2014 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -86.82% | -51.27% |
| 2020 | -178.17% | 104.38% |
| 2019 | -87.17% | -63.4% |
| 2018 | -238.19% | -39.86% |
| 2017 | -396.06% | 139.98% |
| 2016 | -165.04% | -27.03% |
| 2015 | -226.19% | -64.32% |
| 2014 | -633.92% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 STAAR Surgical STAA | 16.10% | -115.69% | 🇺🇸 USA |
 OraSure Technologies OSUR | -4.25% | -95.86% | 🇺🇸 USA |
 AtriCure ATRC | -13.98% | -86.38% | 🇺🇸 USA |
 Biolase
BIOL | -41.06% | -60.00% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.